Year : 2005 | Volume
: 1 | Issue : 4 | Page : 240--248
Indian national cancer control programme: Setting sight on shifting targets
ACTREC, Tata Memorial Centre, Navi Mumbai, India
ACTREC, Tata Memorial Centre, Navi Mumbai
|How to cite this article:|
Sarin R. Indian national cancer control programme: Setting sight on shifting targets.J Can Res Ther 2005;1:240-248
|How to cite this URL:|
Sarin R. Indian national cancer control programme: Setting sight on shifting targets. J Can Res Ther [serial online] 2005 [cited 2019 Dec 7 ];1:240-248
Available from: http://www.cancerjournal.net/text.asp?2005/1/4/240/19603
Along with other chronic non communicable diseases, cancer is gaining increasing importance as a public health issue and affects approximately 0.8 million new cases every year in India., WHO in the year 2000 conducted a global burden of disease study evaluating the Disease Adjusted Life Years (DALY) lost from various chronic non communicable diseases. DALY was used as a combined measure of the years of life lost due to premature mortality in the population and the years of life lost due to disability. The findings of this study showed that in India the 8.7 million Disease Adjusted Life Years lost from cancer was second only to ischaemic heart disease (14 million) and more than stroke (6 million) and diabetes (2 million). Anticipating the emergence of cancer as a public health problem, the Indian National Cancer Control Programme (NCCP) was initiated in 1975 and then revised in 1984 and 1994. The NCCP set itself a very laudable and ambitious goal of reducing the morbidity and mortality from cancer in India. To achieve its goal of reducing the morbidity and mortality from cancer, NCCP chose the most pragmatic approach of prevention and down staging along with better treatment and care for our common cancers. Considering the limited resources devoted to nation's health, some critics then questioned the wisdom of initiating a 'National Control Programme', for a complex life style related disease such as cancer in a country where millions of children and adults were dying of diseases far more preventable and curable than cancer. Nevertheless within two decades, NCCP has proven its utility and has grown beyond a data collection and Telecobalt and morphine distribution exercise. The national control programme in cancer is the most mature and perhaps a good reference for the emerging national programmes for other non communicable chronic diseases in India.
NCCP has been around for a reasonably long time to be judged on its performance and what dividends have come from this national coordinated effort involving several governmental agencies. The best dividend so far has been the National Cancer Registry Programme (NCRP), initiated by ICMR in 1982. Despite some deficiencies in coverage and accuracy, the NCRP data gives us reasonable estimate of the cancer burden in selected urban and rural areas of the country. Very few countries outside the western world have such information on the cross section of their population. Thanks to the NCRP, today we can make emphatic statements such as stomach cancer is more common in Chennai; cancer incidence is much lower in rural Barshi; and that breast cancer has overtaken cervical cancer in most metropolitan cities. We now have trends in cancer incidence over time and also some indicators, though somewhat incomplete, on cancer mortality in selected registries. The NCRP data from selected population and hospital based cancer registries and more recently through the WHO supported Cancer ATLAS project covering many more urban and rural regions, clearly shows the wide variation in the incidence and type of cancers across our vast country. This incidence data has internal consistency and allows us to speculate the underlying reasons behind these intriguing findings and to plan appropriate prevention, treatment and rehabilitation strategies.
The other major dividend of the NCCP is to bring this emerging health problem in sharp focus of the national health agenda by producing consistent data on the burden of cancer; deficiencies in treatment or rehabilitation facilities; and lack of trained personnel. Through its programmes and findings, the NCCP has sensitized and aided not only the health planners but has also made oncologists, whose focus is generally on treatment, more aware of the need for prevention and rehabilitation.
With these two distinct but early achievements, the Indian NCCP is at crossroads where the choice of strategies would decide how soon we would achieve the goals of reducing the morbidity and mortality from cancer. Here I would argue for the case and place of research in a national 'Control' programme for a life-style related disease, positioning research not at the forefront of NCCP but as its 'silent engine of change' along with strategic planning and optimal governmental support.
Rationale for research in a Cancer 'Control' Programme
For the cancers that are common in India, much is already known regarding highly effective ways to prevent, downstage and then cure these down staged cancer. Hence one may question the utility of research by or on behalf of the NCCP for achieving its goals. From its inception, without invoking major research, NCCP made efforts in selecting strategies which it thought would be effective and implemented few pragmatic policies. Nevertheless, lack of 'substantial and demonstrable impact' on the incidence and mortality of cancer, as a direct result of three decades of NCCP programmes, highlights the enormity of the task and the barriers which prevent implementation or fruition of strategies proven in other parts of the world. To achieve the goals of NCCP, a two pronged approach is needed wherein proven and feasible strategies are implemented effectively in parallel with concerted research in several key areas of hope and frustration [Table 1].
As a nation we do believe in research and the field of cancer is no exception. It really is a multi-million dollar question whether we need additional strategies and allocation for research by or on behalf of the NCCP, when research in several aspects of cancer prevention, biology and therapy is being actively pursued by researchers and institutions across the country? Over the past decade, these investigators and institutions have benefited from a larger and better trained workforce as well as increasing funding opportunities through several intramural and extramural programmes of the Indian government, spearheaded by the ICMR, DBT, DST, CSIR, DAE and a few international agencies. However, with the exception of certain national task force programmes and few ICMR programmes, these investigator or institution initiated research programmes are curiosity, opportunity or publication driven research projects and rightly so. While such basic, epidemiological or clinical research should be encouraged and supported, answers from such research programmes may not necessarily provide ready solutions or have 'direct and immediate' relevance for reducing the morbidity and mortality from cancer in the 'population', the overarching goals of the NCCP. This brings out the need for a focussed research approach, designed specifically for the NCCP goals, coordinated and funded either by NCCP or other governmental agencies in synchrony with the NCCP. It is imperative that before launching any major national programme, NCCP should conduct research to test its efficacy, applicability, and cost effectiveness in our unique Indian milieu. More importantly, since most of the existing and supposedly effective approaches do not lend themselves to simple and affordable implementation at the national scale, NCCP would have to conceive, support and test a large number of novel research leads in the hope that at least some of them would prove to be effective and be practical for large scale implementation.
Setting sight on shifting targets
The success of the NCCP in a country as diverse, large and populous as India, will hinge upon the appropriateness of the targets it sets and how it proposes to achieve them within the pre-defined time frame. Lack of objective and relevant goals and targets and their timely achievement has often been the bane of Indian public policy and the NCCP is perhaps no exception. However, with the experience it has gained over three decades [Table 2], NCCP is in a better position of setting realistic goals and specific time bound targets and devise suitable strategies for achieving them [Table 2][Table 3]. The issue is becoming more complicated now with a shifting target, primarily due to the rapid changes in the demography and life style in this diverse and populous country. Life style of the common man is changing fast and is already manifesting in the changing pattern of chronic diseases including the incidence of different cancer types. In addition to the major differences in the incidence of various cancers in different urban and rural areas of India (NCRP and Cancer ATLAS data), some interesting data has emerged from the study of cancer patterns among Indians who have migrated to the United States. Jain et al have recently reported much lower rates of cervical, oral and pharyngeal cancers among Indians living in California as compared to the Indians living in India. In contrast, Indians living in California had a higher rate of prostate, colorectal, breast and lung cancer which is expected to soon reach the white Californian population rate. The Bombay population based registry has also noted decline in oral and cervical cancer incidence with a concomitant rise in breast and lung cancer incidence. Latching on to a shifting target requires accurate analysis of time trends for specific cancers and the underlying causes, coupled with the ability to project future community and patient management needs and then quickly garnering the required resources. One also needs to take into account how changes in other public policies would modulate the risk for specific cancers as exemplified by the programmes for reducing HIV and hepatitis B transmission.
The ongoing major programme for awareness and public health for sexual transmission of HIV will indirectly benefit the NCCP by reducing the HPV transmission and therefore the risk of cervical cancer. Within a decade or two, a major reduction in the incidence of cervical cancer, which is already witnessing a downward trend in several registries, will therefore not be surprising. Screening and vaccination of the entire at risk female population of the country is unlikely to become a reality in the next few decades and by then we expect the cervical cancer rates to have come down substantially due to improving hygienic standards and as a spin off of the HIV crusade. In the meanwhile, ongoing research into cervical cancer screening and vaccination in the Indian milieu may provide some pragmatic and cost effective solutions suitable for screening and vaccination of our high risk population. In the post HPV era, we need further research to accurately define the high risk population, which itself may be several million women, and then test novel or cost effective methods of screening and treatment.
Tobacco Related Cancers
Scenario for the tobacco related cancers is also changing and this has to be seen in the light of changing trends in tobacco consumption as has been brought out in the serial national sample surveys. While there is a trend towards decreasing incidence of oral cancers in few Indian registries, lung cancer is fast becoming the most common cancer in several registries (Cancer ATLAS). The reduction in the oral cancer incidence is explained by the reduction in per capita use of all forms of tobacco including the smokeless form, though reliable long term time trends for gutka use are not yet available. However, the reported reduction in the per capita use of cigarette and beedi smoking from 1987 onwards as observed in the national sample surveys is yet to reflect in a downward trend for lung cancer. Even if some reduction in lung cancer incidence becomes evident in the near future, it will continue to remain a common male cancer in the country. Since unlike oral cancer, lung cancer is not amenable for early detection and offers little scope for cure in advanced stages, primary prevention is the real hope for reducing lung cancer mortality. The same is true for oesophageal cancer.
Based on major trends among the inhabitants of metropolitan Indian cities as well as Indians living in USA, breast cancer will be the most formidable cancer problem for the Indian women [Table 3]. As compared to other cancers, modulating the risk factors for effective primary prevention of breast cancer is the most difficult task. Reproductive factors cannot be reversed to reduce the risk of breast cancer in the present socio-economic state and mammographic screening may neither be feasible nor very efficacious in the relatively younger population of India. Hence our best bet to partially offset the rising tide of breast cancer is through public awareness for adoption of healthier life style, diet, exercise, promoting breast feeding, breast awareness, self or physician breast examination and high risk or opportunistic screening using appropriate technology.
Though childhood cancers account for only a small fraction of all cancers, they deserve special attention in view of the high cure rates possible both for leukaemia and solid tumours and the maximum impact on the disease adjusted life years that can be achieved with optimal treatment. We need few centres of excellence in our country for optimal multidisciplinary treatment, rehabilitation and research in childhood cancers. With a disproportionately larger Indian population in this age group, special emphasis on their curable cancers is very pertinent.
Gall Bladder Cancer
It is now well recognized that gall bladder cancer is becoming one of the most common cancer in women in some regions of north India (Cancer ATLAS). Before the problem reaches epidemic proportion, we need coordinated and focussed research towards understanding of the etio-pathology, early detection and better treatment for the typical presentation of advanced gall bladder cancer.
Several other cancers such as colorectal cancers, stomach cancers, prostate cancers and haemato-lymphoid neoplasia also contribute to the total cancer burden and have shown some interesting trends. For each of these cancers, we need different prevention, early detection and management strategy. Despite the continued economic and technological progress in the country, mass public screening tools for some of these common cancers such as colonoscopy and PSA are unlikely to become feasible within the next few decades. Hence identifying and modulating risk factors, developing affordable yet effective methods for down staging, opportunistic or high risk screening and improved minimum standards of care would be the best option for reducing mortality [Table 4].
Building bridges with other National Health Programmes
Cancer, a life style related disease cannot be seen in isolation from other health threats faced by the country. In fact NCCP and National programmes for non communicable diseases (NCD) such as cardiovascular & diabetes will help each others cause through their common emphasis on healthier life style, diet, tobacco avoidance and physical exercise. Working together with other NCD programmes and by sharing resources and expertise, we have a better chance of making fight against tobacco and other unhealthy life styles as the central point of the nation's long term health agenda. This is the only hope against the rising tide of deaths and disability from most of the common cancers, cardiovascular diseases and diabetes. The spin offs from the crusade against AIDS will also reduce the sexual transmission of HPV, thereby reducing the risk of cervical cancer, as well as reduce the risk of hepatocellular carcinoma by reducing the transfusion and needle acquired transmission of hepatitis B and C virus.
Building infrastructure & human resources for long term goals
Considering the burden of cancer and the public expectation, NCCP has little choice but to set some tough targets in order to diffuse the developing crisis. Taking into account our present and projected cancer burden, infrastructure, human resources, socio-economic status as well as our improving capabilities, we need to set ourselves specific targets for each area as listed in [Table 1][Table 2][Table 3][Table 4][Table 5]. Due to a very long latent period between exposure and disease manifestation and a variable natural history it takes a long time to judge the efficacy of any preventive or therapeutic intervention for cancer. Hence for public health policy for such a disease, it is more important to define, discuss and set the long term goals (10 year) and then work backwards to fix the short term and intermediate targets that should be achieved within the next 5 years. We need to take a holistic view covering the entire spectrum of prevention, therapy, palliative care, regions, human resource and specialities. We have no choice but to grapple with contentious issues of prioritization and relative allocation from the limited resources available for health in general and cancer in particular. Setting aside major NCCP portfolio for primary and secondary prevention in the face of ever increasing demands for providing minimum cancer care services will not be an easy task. However, in order to achieve the long term goal of reducing morbidity and mortality from cancer in the population, prevention and down staging of common and emerging cancers will have to remain at the centre of the NCCP strategy and merit special consideration for resource allocation. Moreover, NCCP through the public health system and NGOs will have to share almost the entire burden of prevention and down staging since the health care industry, hospitals and individual researchers are not expected to make major contributions in this area.
Early detection and awareness initiatives of the NCCP may give rise to a rather piquant situation wherein the demands on cancer departments and hospitals may increase exponentially due to a larger number of early stage curable cancers that require greater expertise and better infrastructure for uncomplicated cures [Table 4][Table 5]. We are also facing ever increasing public expectations and more resources are being devoted even in government funded hospitals for complex, prolonged and resource intensive treatments of advanced cancers, sometimes merely for improving the quality of life of these unfortunate patients. If the cancer diagnosis and treatment facilities are unable to keep pace, the unmet demands may lead to disillusionment among patients, physicians as well as health planners. Since this requires major policy decisions and major fund allocations, this issue needs a very serious thinking and in depth analysis to arrive at a consensus at the earliest. We need to develop working models of alternative financing, including pragmatic and affordable insurance for the cancer patients and investment from the private health care sector to augment the cancer treatment infrastructure.
It really is a billion dollar question from where and when we will get resources to meet the shortfall of 700 teletherapy machines. These 700 machines along with associated civil work, cobalt source and planning equipment, may cost well over Rs 2000 Crores (Rs 20 Billion or 0.4 Billion US Dollar). Since governmental funding can support only a fraction of this demand in the immediate future, one has to explore the model of sharing some of expensive radiotherapy equipments used for treatment planning and Brachytherapy. We also need a major boost and support for the programme for the development of indigenous and cost effective technology [Table 5]. While the initial R&D work will generally be done in government funded centres, it is important to bring the industry partner on board at the earliest for refining and marketing the product. The department of atomic energy has established a very successful model for the development of indigenous telecobalt unit (Bhabhatron), which is now being marketed by the industry (Panacea Medical Technologies Pvt. Ltd, Bangalore). The first Bhabhatron was successfully installed in 2005 and is in clinical use at the Advanced Centre for Treatment Research & Education (ACTREC), Tata Memorial Centre. Several other units of Bhabhatron are likely to be installed in other centres in the near future. The major cost advantage of this indigenous unit over the imported machines can enable us to meet the huge demand in a much shorter period of time. While the present thrust is on affordable and high quality telecobalt unit, the country also needs more affordable linear accelerators, treatment planning equipment and Brachytherapy machines. The new version of the indigenous low energy Linear Accelerator developed by SAMEER, Department of Electronics, IIT Mumbai campus, has recently been installed at Wardha. The 'Apex Committee for the Development Programme of Cancer Institutions in India' set up by the Department of Atomic Energy is coordinating the developmental of several other Brachytherapy and Teletherapy planning and treatment delivery equipments.
Challenges for the NCCP
1.The immediate and most important task for the NCCP is to generate reliable mortality data and some morbidity data for common cancers in the cross section of the Indian population. Like most industrialised nations we should aim to use the more reliable data on cancer mortality and morbidity to judge the cumulative effect of any preventive or therapeutic intervention in the population.
2.Establish a robust system for monitoring pattern of carcinogenic exposure and changes in the composition of carcinogens with special emphasis on Tobacco, industrial and environmental carcinogens. Apex national reference laboratories for Tobacco, Industrial and Viral carcinogens should be identified, strengthened and co-opted into NCCP.
3.Identify the high risk population using research into behavioural, occupational, and socio-economic profiling. For the purpose of NCCP, biological profiling (e.g. host genotype, HPV etc) should be attempted only if other methods are unable to identify this 'high risk population' or the methods of biological profiling are likely to be more cost effective.
4.Through research, identify simple, affordable and effective screening methods for high risk population for our common cancers.
5.Devise and test tailored behavioural interventions for primary prevention.
6.If the standard of care treatment in the west for a particular cancer is not affordable or logistically feasible for 'universal application' in India, build consensus for the minimum acceptable standards of care, considering affordability by the masses or the government and the feasibility of its administration [Table 4].
7.If the consensus minimum accepted standard of care is quite different from the standard of care in the west (e.g. CAF versus Taxanes for breast cancer; radiotherapy versus chemo-radiotherapy for all advanced head and neck cancers), NCCP should initiate or support large and pragmatic multi-centric clinical trials in the Indian community setting comparing compliance, toxicity and efficacy. These parameters in the Indian community and typical government hospital setting may be quite different than what is reported in western or even Indian clinical trial setting. For example we need to ensure that the survival benefit of concurrent chemo-radiotherapy in better nourished and well looked after head and neck cancer patients in the west is not being more than offset by the risk of additional fatal toxicity in our malnourished and dehydrated patients undergoing treatment in a typical government cancer set up and then going back to their communities where they have little health support. Till the time we are able to find resources to improve the general health care set up and supportive facilities, governmental funding for 'western standard of care' regimens which are more effective in trial setting but also more toxic and expensive may need some introspection.
8.Since it will not be feasible for the country to adopt many of the 'western standard of care' treatments for universal application, NCCP should promote pragmatic or novel research for identifying treatment approaches that are at least equivalent or superior in efficacy, or have better compliance and affordability.
9.Treatments that are cost effective and have undergone rigorous clinical testing in trial and community setting should be considered for universal application through governmental support.
10.Treatments that have major curative potential such as chemotherapy for some childhood malignancies and germ cell tumours should also be considered for universal application through governmental support or alternative financing schemes or through NGO support.
11.A model for realistic yet holistic care beyond morphine should be developed for more advanced incurable cancers and then replicated in all parts of the country.
12.The RCCs, Medical Colleges and District Programmes should be strengthened with necessary equipment and training of manpower to fulfil the objectives of the NCCP in a mission mode.
13.Rigorous and regular audit of performance at all levels of planning and implementation of the NCCP programmes.
Cancer undoubtedly is becoming an important public health issue and to tackle it we need immediate and major inputs from various agencies. In decades to come, the health of the nation would become a major determinant of our human and economic wealth and the pace at which we will achieve our rightful place in the world order. Though cancer is not in the United Nations 'Millennium Development Goal' health agenda, based on the emerging trend, WHO has predicted that by the year 2020, almost 70% of the world's 20 million cancers patients will be in the developing nations. In our march towards becoming a healthier, wealthier and pre-eminent nation, coordinated and need based research for understanding the threats to the nation from chronic diseases such as cancer and ways to counter such threats will assume increasing importance. NCCP has started on the right note but to achieve its objectives we need major leads from timely and innovative research which can be implemented across this vast nation in a cost effective manner. I have estimated that the total annual budgetary allocation for cancer care and research from the Indian Government is perhaps less than 1% of the 6 Billion US Dollars research and administration budget of the US National Cancer Institute for the year 2007. While it may take us several decades to match such budgetary allocations for cancer research, even in an under funded national cancer control programme such as ours, research is not a luxury and perhaps more crucial for success than in these affluent nations.
|1||Reddy KS, Shah B, Varghese C, Ramadoss A. Responding to the threat of chronic diseases in India Lancet 2005;366:1746-51.|
|2||http://mohfw.nic.in/kk/95/i9/95i90e01.htm accessed 10.12.05|
|3||http://www.whoindia.org/LinkFiles/Assessment _ of _Burden _of _NCD_Discussion.pdf |
|4||http://www.icmr.nic.in/ncrp/cancer_reg.htm accessed 10.12.05|
|5||http://www.canceratlasindia.org accessed on 11.12.05|
|7||Sarin R. Trends in basic, translational, epidemiological and clinical research in cancer. J Cancer Res Ther 2005;1:4-6.|
|8||Jain RV, Mills PK, Parikh-Patel A. Cancer incidence in the south Asian population of California, 1988-2000. J Carcinog 2005;4:21.|
|9|| In : Reddy KS, Gupta PC, editors. Report on Tobacco Control in India; Ministry of health and family welfare; 2004. |
|10||Sunny L, Yeole BB, Hakama M, Shiri R, Sastry PS, Mathews S, et al . Oral cancers in Mumbai, India: a fifteen years perspective with respect to incidence trend and cumulative risk. Asian Pac J Cancer Prev 2004;5:294-300.|
|11||http://cancercontrolplanet.cancer.gov accessed on 23.12.05|